Virus-like Particles
VLP
We expect enhanced therapeutic effects of pharmaceuticals through precise drug delivery, aiming to provide more effective therapies and improve quality of life.
A Safe and Targeted Drug Delivery System
Virus-like particles (VLPs) are recombined from viruses through genetic engineering technology. The VLP is safety without any infection factors. They can load different types of drugs and deliver them to specific target organs.
Viral shells are like luggage with a set destination
Pathologists have identified that the proteins on the virus shell serve as identification tags. The body recognizes these proteins and directs the virus to specific locations. The virus then uses the siRNA/DNA inside to cause further infection. Essentially, these viral shells are like luggage with a set destination.
Just like Trojan Horse
Researchers use recognizable viruses to encapsulate therapeutic agents like chemicals, proteins, siRNA, or DNA. This approach targets specific sites for delivery, similar to a Trojan Horse. Once at the target, the agents are released for precise treatment.
